BridgeBio Pharma, Inc. (BBIO) vs BrightSpring Health Services, Inc. Common Stock (BTSG)

A side-by-side comparison of BridgeBio Pharma, Inc. and BrightSpring Health Services, Inc. Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — BBIO vs BTSG

growth of $100 · dividends reinvested · last 3y
BBIO +83.4% (+22.4%/yr)BTSG +463.6% (+78.0%/yr)BTSG compounded faster over this window
200400600Start $10020252026$183$564
BBIO BTSG

BBIO vs BTSG: by the numbers

  • •BBIO is the larger company ($12.95B vs $12.17B market cap).
  • •BTSG is profitable (2.05% net margin) while BBIO runs a net loss (-97.64%).
  • •BBIO grew revenue faster over the past five years (62.61% vs 18.92% CAGR).

Metrics side by side

Valuation

MetricBBIOBTSG
P/E ratioN/A46.27
Forward P/EN/A34.10
PEG ratioN/A0.95
P/S ratio18.170.85
P/B ratioN/A5.94
EV / EBITDAN/A21.92
FCF yieldN/A3.31%

Profitability

MetricBBIOBTSG
Gross margin93.35%12.38%
Operating margin-113.35%3.33%
Net margin-97.64%2.05%
ROEN/A14.35%
ROIC-62.14%8.97%

Growth (annualized)

MetricBBIOBTSG
Revenue CAGR (5Y)62.61%18.92%
EPS CAGR (5Y)N/A50.94%
FCF CAGR (5Y)N/A9.24%
Total return CAGR (5Y)7.38%N/A

Frequently asked

Which has grown faster, BBIO or BTSG?
Over the past five years, BBIO grew revenue faster — BBIO at a 62.61% CAGR versus BTSG at 18.92%.
Is BBIO or BTSG more profitable?
BTSG runs the higher net margin — BBIO at -97.64% versus BTSG at 2.05%.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.